000 | 01440 a2200445 4500 | ||
---|---|---|---|
005 | 20250515061414.0 | ||
264 | 0 | _c20070502 | |
008 | 200705s 0 0 eng d | ||
022 | _a0012-3692 | ||
024 | 7 |
_a10.1378/chest.06-2042 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKwon, Yong Soo | |
245 | 0 | 0 |
_aHepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy. _h[electronic resource] |
260 |
_bChest _cMar 2007 |
||
300 |
_a803-808 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntitubercular Agents _xtoxicity |
650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xdiagnosis |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHepatitis C _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKorea |
650 | 0 | 4 | _aLiver Function Tests |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdrug therapy |
700 | 1 | _aKoh, Won-Jung | |
700 | 1 | _aSuh, Gee Young | |
700 | 1 | _aChung, Man Pyo | |
700 | 1 | _aKim, Hojoong | |
700 | 1 | _aKwon, O Jung | |
773 | 0 |
_tChest _gvol. 131 _gno. 3 _gp. 803-808 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1378/chest.06-2042 _zAvailable from publisher's website |
999 |
_c16912045 _d16912045 |